Themed on “Improving cancer care with early detection and prevention”, Abu Dhabi is set to host global and local medical experts in the 1st International Oncology Conference to be held on October 24-25 at Jumeirah at Etihad Towers in Abu Dhabi under the patronage of H.E. Sheikh Nahayan Mabarak Al-Nahayan, Minister of Culture, Youth and Community Development.
Organized by the Scientific Committee and Burjeel Medical City, over 25 experts from leading hospitals in the USA, UK, Austria, Egypt, India and UAE will discuss cutting-edge scientific presentations and comprehensive educational content in cancer research, detection, prevention, treatment and care.The recognized setting of the Conference will provide ideal surroundings for participants to leverage knowledge, promote education and build awareness about oncology - placing the patient at the heart of all the efforts and discussions.
According to HAAD, cancer is the second leading cause of death in the UAE, while in the Middle East it ranks fourth.Commenting on the objective of the conference, Dr. Shamsheer Vayalil, Conference Chairman and Managing Director of Burjeel Hospital and LLH Hospital, said, “Many cancers have a high chance of cure if detected early and treated adequately.Cancer can be reduced and controlled by implementing evidence-based strategies for cancer prevention, early detection of cancer and management of patients withcancer. The conference aims to provide a global platform for global and local medical faculty, government as well as non-government cancer control officials to get together and exchange views on how to deal with cancer.”
The conference is accredited for Continuing Medical Education (CME) hours and will benefit doctors and healthcare professionals from Medical, Surgical and Radiation Oncology, Pathology, Radiology, Obstetrics and Gynecology, Family Medicine, General Practitioners, Pharmacists, Nurses, Researchers, and other healthcare professionals interested in the treatment of cancer disease.
Globally, about 30% of cancer deaths are due to the five leading behavioral and dietary risks: high body mass index, low fruit and vegetable intake, lack of physical activity, tobacco use, alcohol use.While the incidence of cancer in the region is still well below that in western countries, it is expectedto experience the highest increase among all WHO regions in the next 20 years. The rise can be attributed to population ageing due to increased life expectancy, declining fertility, tobacco use, alcohol use, environmental pollution, agricultural carcinogens, unhealthy diet and physical inactivity.
Through interactive sessions and lively debates, the two-day conference is designed to discuss strategies for detecting, preventing, assessing and managing therapies for some of the most frequent types of cancers in the UAE, which are Breast, Colorectal, Lung and Cervical cancers. It will feature recent updates, consolidated knowledge, and conversations on controversial issues regarding prevention, risk factors, imaging & screening,diagnosis, clinical management and new approaches in targeted therapies.
The event is supported by Burjeel Medical City and other key sponsors include Etihad Airways, Roche,Atlas Medical LLC, Sanofi Oncology, Varian Medical System and Gulf Drug amongst several others pharmaceuticals and Diagnostic companies. For registrations to the conference, interested participants can visit www.menaconf.com, contact organizers at 024919888 or email at info@menaconf.com.
|